Thermostable glycosyltransferase variants
By improving the amino acid sequence of glycosyltransferase and binding to β-glucosidase, the problem of natural enzyme instability is solved, higher temperature and chemical stability is achieved, and a green dye production method and bioavailability improvement is provided. solution.
Patent Information
- Application Number
- CN202380023286.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-02-22
- Filing Date
- 2023-02-21
- Publication Date
- 2024-11-15
AI Technical Summary
Natural glycosyltransferases are unstable and difficult to use on industrial scale, limiting their application in enhanced dye and drug bioavailability.
An improved glycosyltransferase mutant was developed to improve the temporal stability, thermal stability and chemical stability of the enzyme through specific amino acid residue substitutions, and combined with beta-glucosidase for the use of indodol compound sugars Mathematically, soluble indigoside is produced to replace the production process of traditional indigo dyes.
It improves the half-life and temperature stability of the enzyme, reduces the sensitivity to organic solvents, avoids the use of strong reducing agents, provides a greener dye production method, and enhances the solubility and bioavailability of the compounds.
Smart Images

Figure CN118974247A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to enzyme mutants having improved temporal, thermal and chemical stability compared to the parent enzyme glycosyltransferase (PtUGT1) from the indigo-producing plant Polygonum tinctorium / Persicaria tinctoria; and to their use in methods for glycosylation of desired compounds (such as indoxyl compounds) to provide a greener alternative to current industrial processes for colored fabrics and other products. Background Art
[0002] Glycosyltransferases, such as UDP-glycosyltransferases (UGTs), can be used in biotechnological applications to attach sugar molecules to a variety of industrial chemicals (e.g., fragrances, dyes, food additives), thereby enhancing their solubility and reducing volatility and toxicity. This can also be used to increase the bioavailability of drugs. However, natural glycosyltransferases are not particularly stable, making them economically unusable on an industrial scale. Summary of the invention
[0003] In one aspect, the present invention provides a polypeptide having glycosyltransferase activity (enzyme classification EC: 2.4.1.-), wherein the amino acid sequence of the polypeptide has at least 75% sequence identity with SEQ ID NO.2, and wherein the amino acid sequence comprises (i) one or more amino acid residue substitutions selected from E75P, Q86K, S110V, I188L, G222D, G296L, V297G, F381V, T388A, S413K and G430K relative to SEQ ID NO 2, and / or (ii) amino acid residue substitutions T388C and A399C relative to SEQ ID NO 2.
[0004] In a preferred embodiment, the present invention provides a polypeptide having glycosyltransferase activity (enzyme classification EC: 2.4.1.-), wherein the amino acid sequence of the polypeptide has at least 75% sequence identity with SEQ ID NO.2, and wherein the amino acid sequence comprises the amino acid residue substitutions E75P, Q86K, S110V, I188L, G222D, G296L, V297G, S413K, G430K and T388A relative to SEQ ID NO 2.
[0005] In another preferred embodiment, the present invention provides a polypeptide having glycosyltransferase activity (enzyme classification EC: 2.4.1.-), wherein the amino acid sequence of the polypeptide has at least 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96 or 97% sequence identity with SEQ ID NO.2, and wherein the amino acid sequence comprises amino acid residue substitutions E75P, Q86K, S110V, I188L, G222D, G296L, V297G, S413K, G430K, F381V and T388A relative to SEQ ID NO.2.
[0006] In another preferred embodiment, the present invention provides a polypeptide having glycosyltransferase activity (enzyme classification EC: 2.4.1.-), wherein the amino acid sequence of the polypeptide has at least 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96 or 97% sequence identity with SEQ ID NO.2, and wherein the amino acid sequence comprises amino acid residue substitutions E75P, Q86K, S110V, I188L, G222D, G296L, V297G, S413K, G430K, F381V, T388C and A399C relative to SEQ ID NO.2.
[0007] In a second aspect, the present invention provides a composition comprising (i) a polypeptide having a glycosyltransferase of the present invention, (ii) a compound comprising a reactive group and (iii) a nucleotide sugar.
[0008] In a third aspect, the present invention provides a kit of parts comprising: (i) a polypeptide having a glycosyltransferase activity according to the present invention, and (ii) a polypeptide having β-glucosidase activity (enzyme classification EC 3.2.1.21).
[0009] In a fourth aspect, the present invention provides a method for glycosylation of a compound, comprising the steps of:
[0010] a. providing (i) a compound comprising a reactive group, (ii) a polypeptide of the present invention having a glycosyltransferase and (iii) a nucleotide sugar,
[0011] b. mixing the components provided in step (a),
[0012] c. reacting the mixture to obtain a glycosylated compound.
[0013] In a fifth aspect, the present invention provides a method for dyeing a product, comprising the steps of:
[0014] d. providing (i) an indoxyl compound, (ii) a polypeptide having a glycosyltransferase of the present invention, (iii) a nucleotide sugar, and (iv) a polypeptide having β-glucosidase activity (enzyme classification EC 3.2.1.21),
[0015] e. mixing components (i), (ii) and (iii) provided in step (a), preferably under reaction conditions in the presence of less than 2% free oxygen,
[0016] f. reacting the mixture to obtain a soluble glycosylated indoxyl dye precursor,
[0017] g. mixing the dye precursor with the product and the β-glucosidase under reaction conditions in which free oxygen is present to obtain a dyed textile,
[0018] The product is selected from the group consisting of yarn, textiles and fabrics.
[0019] In a sixth aspect, the present invention provides use of a polypeptide having a glycosyltransferase of the present invention for glycosylation of a compound, wherein the compound comprises a reactive group. BRIEF DESCRIPTION OF THE DRAWINGS
[0020] Figure 1 : Scheme of glycosylation reactions catalyzed by UDP-glycosyltransferases.
[0021] Figure 2 : (A) The current industrial process, which involves chemically synthesized indigo, and the addition of a reducing agent (e.g., sodium dithionite) to the indigo barrel to achieve reduction to dyeable soluble indigo. In the proposed chemoenzymatic process, indoxyl is glycosylated at the C3 hydroxyl to produce indigo as a product. Glucosides (indigo) are stable and can be stored. During the dyeing step, only the glucose groups on the fabric are removed, allowing the regenerated indoxyl to be oxidized to indigo on the fabric. No reducing agent is required when dyeing with indigo. BGL = β-glucosidase; UGT = UDP-dependent glycosyltransferase. (B) Glucose acts as a protecting group for indoxyl. Removal of glucose by β-glucosidase releases indoxyl, which can be further oxidized by air exposure.
[0022] Figure 3 : (A) and (B) Changes in melting temperatures of mutants designed based on assumed disulfide bond formation relative to PtUGT1 WT.
[0023] Figure 4: Changes in melting temperatures of double and triple mutants combining different beneficial mutations relative to PtUGT1 WT based on assumed disulfide bond formation.
[0024] Figure 5 : (A) and (B) Changes in melting temperatures of mutants designed based on consensus mutagenesis relative to PtUGT1 WT.
[0025] Figure 6 : (A) and (B) Changes in melting temperatures of mutants combining different beneficial mutations based on consensus mutagenesis relative to PtUGT1 WT.
[0026] Figure 7 : Relative activities of Mutant 87, Mutant 88 and Mutant 90 at (A) 40°C, (B) 55°C and (C) 60°C relative to the activity of PtUGT1 WT at 40°C.
[0027] Figure 8 : Relative activities of PtUGT1 WT, mutant 87, mutant 88 and mutant 90 after preincubation at 45°C for different periods of time relative to the activities without preincubation at 45°C.
[0028] Fig. 9 : Relative activities of PtUGT1 WT, mutant 87, mutant 88 and mutant 90 after preincubation at room temperature (22°C) for different periods of time relative to the activities without preincubation at room temperature.
[0029] Fig.10 : Relative activities of PtUGT1 WT, mutant 87, mutant 88, and mutant 90 in the presence of 15% organic solvent (acetone, acetonitrile, or isopropanol) relative to the activity in the absence of organic solvent.
[0030] Fig.11 : Reaction chromatograms showing the presence or absence of product DCP-glucoside in reactions using 4 mM DCP and PtUGT1 WT or mutant 87 enzymes. The reaction with the WT enzyme did not show any product, presumably due to the low chemical stability to DCP. The reaction with mutant 87 showed a clear product peak, confirming the enhanced chemical stability of this variant.
[0031] Fig.12: Kinetics of indigoside synthesis using 100 mM indoxyl-acetate as substrate, 2 U esterase from Bacillus subtilis (Sigma Aldrich) and different concentrations of PtUGT1 / SuSy at a constant molar ratio of 1:5 (50 μg, 20 μg, 10 μg, 5 μg for PtUGT1 WT or Mut 87; and 432.5 μg, 173 μg, 86.7 μg, 43.3 μg for SuSy). The results clearly show that higher concentrations of Mut 87 achieve higher concentrations of indigoside, while the reaction using PtUGT1 WT does not produce any indigoside, presumably due to chemical inactivation of the enzyme at high substrate concentrations.
[0032] Fig.13 : 20 square centimeters of denim disks to be dyed (radius 1.784 cm, diameter 3.57 cm, weight 802 + / - 2 mg) were dyed in 3 mL of pH 9 water with various amounts of indigo (indicated on the graph) and 1 mg of rye β-glucosidase 1. The disks were flipped every 5 min for 15 min at room temperature, then left at room temperature for 1 h, then washed with water and soap, and dried overnight at room temperature. Photos were taken four days after dyeing and after multiple wash / dry cycles. (a) Sample front; (b) Sample back.
[0033] Fig.14 : Receptor for indoxyl derivatives of PtUGT1 WT and mutant variants.
[0034] Fig.15 : Photographs of color development in tubes containing 6-bromoindoxyl after incubation for 90 minutes at 30° C. Tubes from left to right: Tube 1: (-) control without UGT, Tube 2: (-) control without UDP-Glc, Tube 3: (+) control with PtUGT1 WT, Tube 4: with PtUGT1 Mut 87, Tube 5: with PtUGT1 Mut 88, Tube 6: with PtUGT1 Mut 90.
[0035] Fig.16 : Photographs of color development in tubes containing 5-bromo-4-chloro-indoxyl after incubation for 60 minutes at 30° C. From left to right: (A) Tube 1: (-) control without UGT, Tube 2: with PtUGT1 WT, Tube 3: with Mut 87, Tube 4: with Mut 88. (B) Tube 1: (-) control without UGT, Tube 2: with Mut 90.
[0036] Fig.17 : Difference in melting temperature of prior art UGT enzymes compared to PtUGT1 WT.
[0037] Fig.18: Chemical stability. Reaction chromatograms showing the presence or absence of the product DCP-glucoside in reactions using 4 mM DCP and (a) PtUGT1 WT, (b) PtUGT2, (c) PtIGS, or (d) Mutant 87 enzymes.
[0038] Abbreviations, Terms and Definitions
[0039] Amino acid sequence identity: As used herein, the term "sequence identity" indicates a quantitative measure of the degree of similarity between two amino acid sequences of substantially equal length. The two sequences to be compared must be aligned to obtain the best fit, which is performed by inserting a gap at the end of the protein sequence or alternatively truncating it. Sequence identity can be calculated as ((Nref-Ndif)100) / (Nref), where Ndif is the total number of residues that are not identical in the two sequences when aligned, and where Nref is the number of residues in a sequence. Sequence identity calculations are preferably automated using BLAST programs, such as BLASTP programs (Pearson WR and DJ Lipman (1988)) (www.ncbi.nlm.nih.gov / cgi-bin / BLAST). Program MAFFT24 (Multiple Alignment using Fast Fourier Transform; Katoh et al., 2019) can be used to perform sequence alignment using default parameters (scoring matrix: blosum62, gap open penalty: 1.53, gap extension penalty 0.123).
[0040] Preferably, the number of substitutions, insertions, additions or deletions of one or more amino acid residues in a polypeptide compared to its comparator polypeptide is limited, i.e., no more than 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10 substitutions, no more than 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10 insertions, no more than 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10 additions, and no more than 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10 deletions. Preferably, the substitutions are conservative amino acid substitutions: exchanges limited to members of Group 1: glycine, alanine, valine, leucine, isoleucine; Group 2: serine, cysteine, selenocysteine, threonine, methionine; Group 3: proline; Group 4: phenylalanine, tyrosine, tryptophan; Group 5: aspartic acid, glutamic acid, asparagine, glutamine; Group 6: histidine, lysine, arginine.
[0041] As used herein, the melting temperature (Tm (°C)) of a protein defines the temperature (Tm) at which the folded and unfolded states are equally distributed at equilibrium (assuming the two-state protein is folded), which is the denaturation midpoint of the protein, and is measured by using a thermal drift assay (such as, the Protein Thermal Drift Dye Kit (ThermoFisher Scientific) and a qPCR QuantStudio5 machine, see the Examples section).
[0042] The half-life / shelf life time is defined as the amount of time an enzyme can be pre-incubated at a defined temperature so that it has 50% residual activity compared to the activity without pre-incubation.
[0043] Indoxyl compounds are defined herein as indoxyl, thioindoxyl and any indoxyl or thioindoxyl derivative having an unprotected (reactive) thio or hydroxyl group at position 3. Indoxyl derivatives may contain halogen substitutions on the ring structure. Examples of indoxyl derivatives include, but are not limited to: 6-bromo-indoxyl, 5-bromo-4-chloro-indoxyl, 6-chloro-indoxyl, 5-bromo-indoxyl, 5-bromo-6-chloro-indoxyl, thioindoxyl, 5-bromo-7-bromo-indoxyl.
[0044] A reactive group is defined herein as a chemical group that can be glycosylated by a glycosyltransferase.
[0045] Free oxygen is defined herein as molecular oxygen or dioxygen.
[0046] Dye precursors are defined herein as compounds which, after one or more chemical transformations, can give rise to dyed materials.
[0047] Nucleotide sugars are defined herein as molecules in which a sugar is bound to a nucleotide via a glycosidic bond; wherein the sugar is a monosaccharide such as glucose, rhamnose, xylose, arabinose. Nucleotide sugars act as glycosyl donors in glycosylation reactions; those reactions are catalyzed by glycosyltransferases.
[0048] A mutant enzyme (or enzyme variant) is an enzyme that comprises one or more amino acid substitutions compared to the wild-type enzyme. DETAILED DESCRIPTION
[0049] The present invention provides improved glycosyltransferases.
[0050] As mentioned above, glycosyltransferases can be used in a variety of applications to attach sugar molecules to various compounds, thereby enhancing their solubility and reducing volatility and potential toxicity.
[0051] Specifically, UDP-dependent glycosyltransferases (UGTs) are a superfamily of enzymes that catalyze glycosylation and help transfer sugar groups from UDP-sugar donors to a variety of compounds. The enzymatic reaction is proposed to occur by deprotonation of the acceptor hydroxyl group by a highly conserved histidine residue in the active site of the UGT. - This is followed by a nucleophilic attack at the C1 of the sugar donor to form a glycosidic bond ( Figure 1 ).
[0052] UGTs can glycosylate many different chemicals, including indoxyl (a precursor of indigo dye). Specifically, UGT enzyme variants could serve as green biotech alternatives to the current industrial process for blue denim production ( Figure 2 ).
[0053] Blue denim is traditionally dyed with chemically synthesized indigo under harsh and environmentally challenging conditions. Indigo is formed spontaneously from indoxyl by air oxidation as the last step in the synthesis, but in order to be used for dyeing, indigo also needs to be treated with a strong reducing agent (e.g., Na 2 S 2 O 4 ) solubilization, which is also environmentally challenging.
[0054] The improved, ultra-stable glycosyltransferase variants described herein can be added to current industrial processes, thereby eliminating the 'dirty chemistry' step in blue denim dyeing. Specifically, the hydroxyl groups of chemically synthesized indoxylphenol can be glycosylated by glycosyltransferases, thereby protecting the reactive functional groups and generating stable soluble (colorless) indigo molecule. Indigo can then be hydrolyzed to indoxyl by β-glucosidase (BGL), which can then spontaneously oxidize to form blue indigo directly on the fabric. The present invention provides a "greener" alternative to current industrial processes by providing an alternative solution for the final step of the indigo dyeing process, thereby avoiding the use of irritating strong reducing agents.
[0055] The present application is equally applicable to similar indoxyl dye compounds.
[0056] I. Improved UGT enzymes
[0057] In one aspect, the present invention provides an improved glycosyltransferase mutant enzyme having improved functional properties relative to the parent (wild-type) enzyme from which the mutant is derived. Specifically, the glycosyltransferase mutant enzyme of the present invention is derived from PtUGT1 (SEQ ID NO 2) and has the following properties:
[0058] Melting temperature rises ( Figure 6 )
[0059] ·Equivalent activity at 40°C Figure 7 A)
[0060] Active at 55°C and even 60°C, whereas the wild-type enzyme is inactive at these temperatures ( Figure 7 B and 7C)
[0061] Half-life increased, at least 216-fold for Mut 87, 144-fold for Mut 88, and 72-fold for Mut 90 at 45°C Figure 8 )
[0062] Increased tolerance to different organic solvents ( Fig.10 )
[0063] Different indoxyl compounds can be stabilized by forming glycosylated soluble dye precursors ( Fig.12 , 15 and 16), and can therefore be used in dyeing applications such as denim dyeing ( Fig.13 ).
[0064] As part of the natural processing of proteins in microorganisms, leading methionine amino acid residues are naturally removed and are therefore not part of the final mature protein. Therefore, references to specific amino acid positions in the amino acid sequence of the wild-type PtUGT1 enzyme are preferably made using the amino acid sequence without the leading methionine. In the present application, SEQ ID NO.2 and SEQ ID NO.195 both represent the amino acid sequence of the wild-type PtUGT1, the only difference being that SEQ ID NO.2 does not contain a leading methionine residue, while SEQ ID NO.195 contains a leading methionine residue.
[0065] The mutant glycosyltransferase of the present invention has glycosyltransferase activity (enzyme classification EC: 2.4.1.-) for glycosylation of a selected compound having a reactive group. The mutant enzyme has at least 75% sequence identity with the wild-type UDP-dependent glycosyltransferase from Polygonum indigoferum (PtUGT1, SEQ ID NO. 2), but comprises one or more specific mutations relative to the sequence of PtUGT1. Specifically, the mutant comprises (i) one or more amino acid residue substitutions selected from E75P, Q86K, S110V, I188L, G222D, G296L, V297G, F381V, T388A, S413K and G430K relative to the amino acid sequence of PtUGT1, and / or (ii) amino acid residue substitutions T388C and A399C relative to the amino acid sequence of PtUGT1.
[0066] In one embodiment, the mutant glycosyltransferase of the present invention has glycosyltransferase activity, and the amino acid sequence of the enzyme comprises one or more amino acid substitutions disclosed above relative to the PtUGT1 parent (wild-type) enzyme, and also has at least 75% sequence identity with PtUGT1 (SEQ ID NO.: 2), such as at least 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97% sequence identity with PtUGT1 (SEQ ID NO.: 2).
[0067] In one embodiment, the invention provides a polypeptide having glycosyltransferase activity (enzyme classification EC: 2.4.1.-), wherein the amino acid sequence of the polypeptide has at least 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97% sequence identity with SEQ ID NO.2, and wherein the amino acid sequence comprises (i) one or more amino acid residue substitutions selected from E75P, Q86K, S110V, I188L, G222D, G296L, V297G, F381V, T388A, S413K and G430K relative to SEQ ID NO.2, and / or (ii) amino acid residue substitutions T388C and A399C.
[0068] In one embodiment, the present invention provides a polypeptide having glycosyltransferase activity (enzyme classification EC: 2.4.1.-), wherein the amino acid sequence of the polypeptide has at least 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97% sequence identity with SEQ ID NO.2, and wherein the amino acid sequence comprises amino acid residue substitutions E75P, Q86K, S110V, I188L, G222D, G296L, V297G, S413K and G430K relative to SEQ ID NO.2.
[0069] In one embodiment, the present invention provides a polypeptide having glycosyltransferase activity (enzyme classification EC: 2.4.1.-), wherein the amino acid sequence of the polypeptide has at least 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97% sequence identity with SEQ ID NO.2, and wherein the amino acid sequence comprises (i) amino acid residue substitutions E75P, Q86K, S110V, I188L, G222D, G296L, V297G, S413K and G430K relative to SEQ ID NO.2, and (iia) one or more amino acid residue substitutions selected from F381V and T388A relative to SEQ ID NO.2.
[0070] In one embodiment, the present invention provides a polypeptide having glycosyltransferase activity (enzyme classification EC: 2.4.1.-), wherein the amino acid sequence of the polypeptide has at least 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97% sequence identity with SEQ ID NO.2, and wherein the amino acid sequence comprises (i) amino acid residue substitutions E75P, Q86K, S110V, I188L, G222D, G296L, V297G, S413K and G430K relative to SEQ ID NO.2, and (iib) amino acid residue substitutions T388C and A399C relative to SEQ ID NO.2.
[0071] In one embodiment, the invention provides a polypeptide having glycosyltransferase activity (enzyme classification EC: 2.4.1.-), wherein the amino acid sequence of the polypeptide has at least 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96 or 97% sequence identity with SEQ ID NO.2, and wherein the amino acid sequence comprises (i) amino acid residue substitutions E75P, Q86K, S110V, I188L, G222D, G296L, V297G, S413K and G430K relative to SEQ ID NO.2, and (iia) one or more amino acid residue substitutions selected from F381V and T388A, and (iib) amino acid residue substitutions T388C and A399C relative to SEQ ID NO.2.
[0072] In a preferred embodiment, the present invention provides a polypeptide having glycosyltransferase activity (enzyme classification EC: 2.4.1.-), wherein the amino acid sequence of the polypeptide has at least 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96 or 97% sequence identity with SEQ ID NO.2, and wherein the amino acid sequence comprises amino acid residue substitutions E75P, Q86K, S110V, I188L, G222D, G296L, V297G, S413K, G430K and T388A relative to SEQ ID NO.2.
[0073] In a most preferred embodiment, the present invention provides a polypeptide having glycosyltransferase activity (enzyme classification EC: 2.4.1.-), wherein the amino acid sequence of the polypeptide is SEQ ID NO.4.
[0074] In the present application, SEQ ID NO. 4 and SEQ ID NO. 196 both represent the amino acid sequence of Mut97, the only difference being that SEQ ID NO. 4 contains a leading methionine residue, while SEQ ID NO. 196 does not contain a leading methionine residue.
[0075] In another preferred embodiment, the present invention provides a polypeptide having glycosyltransferase activity (enzyme classification EC: 2.4.1.-), wherein the amino acid sequence of the polypeptide has at least 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96 or 97% sequence identity with SEQ ID NO.2, and wherein the amino acid sequence comprises amino acid residue substitutions E75P, Q86K, S110V, I188L, G222D, G296L, V297G, S413K, G430K, F381V and T388A relative to SEQ ID NO.2.
[0076] In another most preferred embodiment, the present invention provides a polypeptide having glycosyltransferase activity (enzyme classification EC: 2.4.1.-), wherein the amino acid sequence of the polypeptide is SEQ ID NO.6.
[0077] In the present application, SEQ ID NO. 6 and SEQ ID NO. 197 both represent the amino acid sequence of Mut88, the only difference being that SEQ ID NO. 6 includes a leading methionine residue, while SEQ ID NO. 197 does not include a leading methionine residue.
[0078] In another preferred embodiment, the present invention provides a polypeptide having glycosyltransferase activity (enzyme classification EC: 2.4.1.-), wherein the amino acid sequence of the polypeptide has at least 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96 or 97% sequence identity with SEQ ID NO.2, and wherein the amino acid sequence comprises amino acid residue substitutions E75P, Q86K, S110V, I188L, G222D, G296L, V297G, S413K, G430K, F381V, T388C and A399C relative to SEQ ID NO.2.
[0079] In another most preferred embodiment, the present invention provides a polypeptide having glycosyltransferase activity (enzyme classification EC: 2.4.1.-), wherein the amino acid sequence of the polypeptide is SEQ ID NO.8.
[0080] In the present application, SEQ ID NO. 8 and SEQ ID NO. 198 both represent the amino acid sequence of Mut90, the only difference being that SEQ ID NO. 8 contains a leading methionine residue, while SEQ ID NO. 198 does not contain a leading methionine residue.
[0081] In a preferred embodiment, the polypeptide of the present invention has UPD-dependent glycosyltransferase activity. In another preferred embodiment, the polypeptide of the present invention has indoxyl-UDPG glucosyltransferase activity (enzyme classification EC: 2.4.1.220).
[0082] The mutant glycosyltransferase of the present invention has glycosyltransferase activity (enzyme classification EC: 2.4.1.-) for glycosylation of a selected compound having a reactive group. The mutant enzyme has at least 75% sequence identity with the wild-type UDP-dependent glycosyltransferase from Polygonum indigoferum (PtUGT1, SEQ ID NO. 195), but comprises one or more specific mutations relative to SEQ ID NO. 195. Specifically, the mutant comprises (i) one or more amino acid residue substitutions selected from E76P, Q87K, S111V, I189L, G223D, G297L, V298G, F381V, T389A, S414K and G431K relative to SEQ ID NO. 195, and / or (ii) amino acid residue substitutions T389C and A400C relative to SEQ ID NO. 195.
[0083] In one embodiment, the mutant glycosyltransferase of the invention has glycosyltransferase activity, and the amino acid sequence of the enzyme comprises one or more amino acid substitutions disclosed above relative to SEQ ID NO.195, and also has at least 75% sequence identity with SEQ ID NO.195, such as at least 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97% sequence identity with SEQ ID NO.195.
[0084] In one embodiment, the invention provides a polypeptide having glycosyltransferase activity (enzyme classification EC: 2.4.1.-), wherein the amino acid sequence of the polypeptide has at least 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97% sequence identity with SEQ ID NO. 195, and wherein the amino acid sequence comprises (i) one or more amino acid residue substitutions selected from E76P, Q87K, S111V, I189L, G223D, G297L, V298G, F3812V, T389A, S414K and G431K relative to SEQ ID NO. 195, and / or (ii) amino acid residue substitutions T389C and A400C.
[0085] In one embodiment, the invention provides a polypeptide having glycosyltransferase activity (enzyme classification EC: 2.4.1.-), wherein the amino acid sequence of the polypeptide has at least 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97% sequence identity with SEQ ID NO.195, and wherein the amino acid sequence comprises amino acid residue substitutions E76P, Q87K, S111V, I189L, G223D, G297L, V298G, S414K and G431K relative to SEQ ID NO.195.
[0086] In one embodiment, the present invention provides a polypeptide having glycosyltransferase activity (enzyme classification EC: 2.4.1.-), wherein the amino acid sequence of the polypeptide has at least 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97% sequence identity with SEQ ID NO.195, and wherein the amino acid sequence comprises (i) amino acid residue substitutions E76P, Q87K, S111V, I189L, G223D, G297L, V298G, S414K and G431K relative to SEQ ID NO.195, and (iia) one or more amino acid residue substitutions selected from F382V and T389A relative to SEQ ID NO.195.
[0087] In one embodiment, the present invention provides a polypeptide having glycosyltransferase activity (enzyme classification EC: 2.4.1.-), wherein the amino acid sequence of the polypeptide has at least 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97% sequence identity with SEQ ID NO.195, and wherein the amino acid sequence comprises (i) amino acid residue substitutions E76P, Q87K, S111V, I189L, G223D, G297L, V298G, S414K and G431K relative to SEQ ID NO.195, and (iib) amino acid residue substitutions T389C and A400C relative to SEQ ID NO.195.
[0088] In one embodiment, the invention provides a polypeptide having glycosyltransferase activity (enzyme classification EC: 2.4.1.-), wherein the amino acid sequence of the polypeptide has at least 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96 or 97% sequence identity with SEQ ID NO.195, and wherein the amino acid sequence comprises (i) amino acid residue substitutions E76P, Q87K, S111V, I189L, G223D, G297L, V298G, S414K and G431K relative to SEQ ID NO.195, and (iia) one or more amino acid residue substitutions selected from F382V and T389A, and (iib) amino acid residue substitutions T389C and A400C relative to SEQ ID NO.195.
[0089] In a preferred embodiment, the present invention provides a polypeptide having glycosyltransferase activity (enzyme classification EC: 2.4.1.-), wherein the amino acid sequence of the polypeptide has at least 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96 or 97% sequence identity with SEQ ID NO.195, and wherein the amino acid sequence comprises amino acid residue substitutions E76P, Q87K, S111V, I189L, G223D, G297L, V298G, S414K, G431K and T389A relative to SEQ ID NO.195.
[0090] In a most preferred embodiment, the present invention provides a polypeptide having glycosyltransferase activity (enzyme classification EC: 2.4.1.-), wherein the amino acid sequence of the polypeptide is SEQ ID NO.196.
[0091] In the present application, SEQ ID NO. 4 and SEQ ID NO. 196 both represent the amino acid sequence of Mut97, the only difference being that SEQ ID NO. 4 contains a leading methionine residue, while SEQ ID NO. 196 does not contain a leading methionine residue.
[0092] In another preferred embodiment, the present invention provides a polypeptide having glycosyltransferase activity (enzyme classification EC: 2.4.1.-), wherein the amino acid sequence of the polypeptide has at least 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96 or 97% sequence identity with SEQ ID NO.195, and wherein the amino acid sequence comprises amino acid residue substitutions E76P, Q87K, S111V, I189L, G223D, G297L, V298G, S414K, G431K, F382V and T389A relative to SEQ ID NO.195.
[0093] In another most preferred embodiment, the present invention provides a polypeptide having glycosyltransferase activity (enzyme classification EC: 2.4.1.-), wherein the amino acid sequence of the polypeptide is SEQ ID NO.197.
[0094] In the present application, SEQ ID NO. 6 and SEQ ID NO. 197 both represent the amino acid sequence of Mut88, the only difference being that SEQ ID NO. 6 includes a leading methionine residue, while SEQ ID NO. 197 does not include a leading methionine residue.
[0095] In another preferred embodiment, the present invention provides a polypeptide having glycosyltransferase activity (enzyme classification EC: 2.4.1.-), wherein the amino acid sequence of the polypeptide has at least 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96 or 97% sequence identity with SEQ ID NO.195, and wherein the amino acid sequence comprises amino acid residue substitutions E76P, Q87K, S111V, I189L, G223D, G297L, V298G, S414K, G431K, F382V, T389C and A400C relative to SEQ ID NO.195.
[0096] In another most preferred embodiment, the present invention provides a polypeptide having glycosyltransferase activity (enzyme classification EC: 2.4.1.-), wherein the amino acid sequence of the polypeptide is SEQ ID NO.198.
[0097] In the present application, SEQ ID NO. 8 and SEQ ID NO. 198 both represent the amino acid sequence of Mut90, the only difference being that SEQ ID NO. 8 contains a leading methionine residue, while SEQ ID NO. 198 does not contain a leading methionine residue.
[0098] II. Compositions Comprising Mutant UGT Enzymes
[0099] In a second aspect, the present invention provides a composition comprising (i) a polypeptide having glycosyltransferase activity as disclosed in Section I, (ii) a compound comprising a reactive group and (iii) a nucleotide sugar.
[0100] In some cases, the reactive groups of the compound to be glycosylated may react with oxygen in the presence of oxygen, such as in competition with an enzymatic glycosylation reaction. In such cases, it may therefore be advantageous to provide a hypoxic, anaerobic or substantially anaerobic environment for the glycosylation reaction to occur.
[0101] In one embodiment, the compositions of the invention are substantially oxygen-free. In one embodiment, the compositions of the invention contain less than 2% free oxygen, such as less than 1.5, 1, 0.5, or even less than 0.1% free oxygen, and / or maintain a pressure of less than 10, 9, 8, 7, 6, 5, 4, 3, 2 kPa, or even less than 1 kPa to reduce the likelihood of oxidation of reactive groups of the compound.
[0102] In one embodiment, the reactive group of the compound in the composition is a hydroxyl group. In one embodiment, the compound comprising the reactive group is an indoxyl compound, and the composition is suitable for obtaining a stabilized dye precursor because the indoxyl compound is glycosylated by a glycosyltransferase. In a preferred embodiment, the compound comprising the reactive group is selected from indoxyl, 6-bromo-indoxyl, 5-bromo-4-chloro-indoxyl, 6-chloro-indoxyl, 5-bromo-indoxyl, 5-bromo-6-chloro-indoxyl, thioindoxyl and 5-bromo-7-bromo-indoxyl.
[0103] In one embodiment, the polypeptide having carbonyltransferase activity as disclosed in Section I is a UPD-dependent glycosyltransferase, and the nucleotide sugar is a UPD-sugar, such as UDP-glucose, UPD-rhamnose, UPD-xylose and UPD-arabinose. In a preferred embodiment, the nucleotide sugar of the composition is UDP-glucose.
[0104] In the most preferred embodiment, the compound comprising a reactive group is indoxyl, which is converted to indigoside, a stable precursor of indigo, by a glycosyltransferase.
[0105] III. Multi-part kit
[0106] In a third aspect, the invention provides a kit of parts comprising (i) a polypeptide having glycosyltransferase activity as disclosed in part I, and (ii) a polypeptide encoding a beta-glucosidase (BGL) (enzyme class EC 3.2.1.21).
[0107] The multi-part kit of the present invention comprises a glycosyltransferase as defined herein and a BGL enzyme as defined herein. Taking their effects on indoxyl as an example ( Figure 2 B), these enzymes catalyze separate reactions: first, the glycosyltransferase glycosylates the indoxyl compound and thereby stabilizes it (ie, forms indigo), and then, under the desired reaction conditions, the BLG deglycosylates the indigo to recover the reactive indoxyl compound.
[0108] Those skilled in the art will be familiar with methods of providing different enzymes for the kit of the present invention. Such enzymes can be produced, for example, by microorganisms (such as recombinant or produced by natural producers), or can be synthetic. The enzyme can be provided in solution or dry form. The enzyme can be premixed or provided in a separate container.
[0109] III.i Glycosyltransferase
[0110] For details concerning the polypeptide having glycosyltransferase activity of the kit of the present invention, see Section I of the present application.
[0111] III.ii β-Glucosidase
[0112] Beta-glucosidase (BGL) catalyzes the cleavage of glycosidic bonds, and for the purposes of the present invention, is used to remove glucose from glycosylated compounds. This removal of (protective) sugar molecules converts the compound back into its reactive form. In the case where the compound is an indoxyl compound, it can spontaneously dimerize in a reactive form under aerobic conditions.
[0113] In one embodiment the BGL is selected from the group of enzymes classified as EC 3.2.1.21.
[0114] In one embodiment, the amino acid sequence of BGL is an amino acid sequence having at least 70, 71, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100% sequence identity to SEQ ID NO. 9, 10 or 11.
[0115] In a preferred embodiment, the amino acid sequence of BGL is an amino acid sequence having at least 70, 71, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100% sequence identity with SEQ ID NO.9.
[0116] III.iii Nucleotide sugar
[0117] Kit can also include nucleotide sugars, which are necessary for the glycosylation reaction catalyzed by glycosyltransferase. In one embodiment, nucleotide sugars are UPD-sugars, such as UDP-glucose, UPD-rhamnose, UPD-xylose and UPD-arabinose. In a preferred embodiment, nucleotide sugars are UDP-glucose. UDP-glucose can be directly provided as UDP-glucose, or indirectly provided as other sugars or sugar-containing molecules, and then the sugar or sugar-containing molecules are converted into UDP-glucose. This example of indirectly providing UPD-glucose is that sucrose is provided together with UDP, and then converted into UDP-glucose by enzymatic catalysis (such as using sucrose synthase (SuSy) EC 2.4.1.13), as shown in Example 4.1. Another example of indirect provision of UPD-glucose is the use of sucrose phosphorylase (converts sucrose and phosphate to glucose-1-P and fructose), glucose-1-phosphate uridyltransferase (converts UTP and glucose-1-P to UDP-glucose and PPi); and further regeneration of UTP from UDP using acetate kinase (converts acetyl-P+UDP to UTP+acetate) which requires an equimolar amount of acetyl-P as substrate (Lee et al. 2004, Bruyn et al. 2015).
[0118] The kit may also include buffers and other related reagents for maintaining the activity of the enzyme and / or enhancing the effect of the enzyme.
[0119] Finally, the kit may also include an instruction manual providing details of each kit component and / or a description of methods of using the kit components.
[0120] IV. Methods Involving Improved UGT Enzymes
[0121] In a fourth aspect, various methods involving the mutant glycosyltransferases of the invention are provided, wherein the glycosyltransferase catalyzes the glycosylation of a compound of interest.
[0122] IV.i Methods for Glycosylation of Compounds
[0123] In a fourth aspect, the present invention provides a method for glycosylation of a compound, comprising the steps of:
[0124] a. providing (I) a compound comprising a reactive group, (II) a polypeptide of the invention (as disclosed in part I) having glycosyltransferase activity and (iii) a nucleotide sugar,
[0125] b. mixing the components provided in step (a),
[0126] c. reacting the mixture to obtain a glycosylated compound.
[0127] As disclosed herein, the mutant glycosyltransferases of the present invention have glycosyltransferase activity for glycosylation of selected compounds comprising a reactive group.
[0128] In one embodiment, the compound comprising a reactive group is an indoxyl compound. In a preferred embodiment, the indoxyl compound is selected from indoxyl, 6-bromo-indoxyl, 5-bromo-4-chloro-indoxyl, 6-chloro-indoxyl, 5-bromo-indoxyl, 5-bromo-6-chloro-indoxyl, thioindoxyl and 5-bromo-7-bromo-indoxyl. In a most preferred embodiment, the compound comprising a reactive group is indoxyl.
[0129] In addition, as disclosed above, nucleotide sugars must be present to realize the occurrence of the reaction, but can be provided directly or indirectly as described in part III.iii. In one embodiment, the method for the glycosylation of selected compounds comprises providing UDP-glucose. In another embodiment of the step (a) of the method, a sugar molecule is provided, whose son can be converted into nucleotide sugars, preferably UDP-glucose, such as by enzymatic catalysis.
[0130] The reaction conditions of the method may depend on what the target compound for glycosylation is.
[0131] In some cases, the reactive groups of the compound to be glycosylated may react with oxygen in the presence of oxygen, such as in competition with an enzymatic glycosylation reaction. In such cases, it may therefore be advantageous to provide a hypoxic, anaerobic or substantially anaerobic environment for the glycosylation reaction to occur.
[0132] In one embodiment, step (b) of the method of glycosylation of a compound is carried out under conditions with less than 2% free oxygen, such as less than 1.5, 1, 0.5 or even less than 0.1% free oxygen, and / or a pressure of less than 10, 9, 8, 7, 6, 5, 4, 3, 2 kPa or even less than 1 kPa is maintained to reduce the possibility of oxidation of reactive groups of the compound. In one embodiment, the reactive group of the glycosylation of the target compound is a hydroxyl group.
[0133] In one embodiment, when the target compound for glycosylation is an indoxyl compound, the reaction preferably occurs under low oxygen, substantially anaerobic or even anaerobic conditions to ensure that the reactive indoxyl compound does not spontaneously dimerize. In one embodiment, when the target compound for glycosylation is an indoxyl compound, the reaction preferably occurs under conditions containing less than 2% free oxygen (such as, less than 2, 1.5, 1, 0.5 or even less than 0.1%) and / or reduced pressure (such as, less than 10, 9, 8, 7, 6, 5, 4, 3, 2 or even less than 1 kPa) to reduce the possibility of spontaneous dimerization of the reactive indoxyl compound, such as dimerization of indigo.
[0134] The compound containing the reactive group is preferably incubated with the glycosyltransferase under temperature and pH conditions that are optimal for the enzyme. In one embodiment, the incubation temperature applied should be in the range of 20-65° C., such as 20-60° C., such as 30-60° C., such as 40-55° C., preferably in the range of 45-55° C., such as preferably about 50° C. In one embodiment, the incubation pH applied should be in the range of pH 5-9, such as pH 5.5-8.5, such as preferably pH 6-8.
[0135] The enzymatic reaction may be carried out in a buffer solution for stabilizing the enzyme, as known and routinely optimized by those skilled in the art.
[0136] The glycosylated compounds produced by the method of the present invention can be detected by HLPC-UV, LC-MS, NMR or similar equipment known to those skilled in the art.
[0137] IV.ii. Method for producing soluble dye precursors
[0138] As disclosed above, indoxyl compounds can dimerize under aerobic conditions and form colored compounds that can be used as dyes, such as for dyeing fabrics or other products. These dimerized colored compounds are insoluble in aqueous solutions. Glycosylation of the indoxyl compounds will stabilize the compounds, prevent dimerization, and thus provide soluble dye precursors.
[0139] In one embodiment, there is provided a method for producing a soluble dye precursor comprising the steps of:
[0140] a. providing (i) an indoxyl compound, (ii) a polypeptide of the present invention (as disclosed in part I) having glycosyltransferase activity and (iii) a nucleotide sugar,
[0141] b. mixing the components provided in step (a), preferably under reaction conditions in the presence of less than 2% free oxygen,
[0142] c. reacting the mixture to obtain a glycosylated soluble indoxyl dye precursor.
[0143] The reaction conditions specified in section IV.i. apply equally to this process for producing soluble dye precursors.
[0144] IV.iii A method for dyeing a product such as yarn or textile
[0145] The mutant glycosyltransferases of the invention are particularly useful in enzyme-catalyzed processes for dyeing products such as yarns or textiles, thus providing an alternative to current chemical processes.
[0146] In one embodiment, the method for producing a soluble dye precursor disclosed in section IV.ii further comprises dyeing the product of interest, further comprising the steps of:
[0147] d. mixing the glycosylated soluble indoxyl dye precursor with the product of interest and a polypeptide having beta-glucosidase activity (enzyme classification EC 3.2.1.21) under reaction conditions in which free oxygen is present to obtain a dyed product.
[0148] In one embodiment, the present invention provides a method for dyeing a product, comprising the steps of:
[0149] a. providing (i) an indoxyl phenol compound, (ii) a polypeptide having glycosyltransferase activity as disclosed in part I, (iii) a nucleotide sugar and (iv) a polypeptide having β-glucosidase activity,
[0150] b. mixing components (i), (ii) and (iii) provided in step (a), preferably under reaction conditions in the presence of less than 2% free oxygen,
[0151] c. reacting the mixture to obtain a soluble glycosylated indoxyl dye precursor,
[0152] d. mixing the dye precursor with the product and the β-glucosidase under reaction conditions in which free oxygen is present to obtain a dyed product.
[0153] In one embodiment, the product intended for dyeing by the method disclosed herein can be selected from yarn, textile, fabric and similar products. In a preferred embodiment, the product is yarn or textile.
[0154] About step (a), (b) and (c), the reaction conditions specified in part IV.i are equally applicable to this method for textile dyeing. About step (d), the product intended for dyeing is mixed with a dye precursor, and the method also comprises mixing / adding beta-glucosidase, then the step of deglycosylation of indoxyl compound. Such beta-glucosidase is described in part III.ii. Preferably, this part of the method occurs under aerobic conditions, so that the indoxyl compound dimerizes spontaneously and forms a colored dye.
[0155] In a preferred embodiment, the indoxyl compound used in the method for dyeing a product is indoxyl, the dye precursor is indigo, and the final dyed product is dyed by indigo. In a more preferred embodiment, the final dyed product is a textile.
[0156] V. Use of Improved UGT Enzymes
[0157] In a fifth aspect, the present invention discloses the use of a polypeptide having glycosyltransferase activity as disclosed in section I for glycosylation of a compound, wherein the compound comprises a reactive hydroxyl group.
[0158] In a preferred embodiment, the compound is an indoxyl compound and the glycosylated compound is used as a dye precursor in a process for dyeing textiles.
[0159] VI. Advantages and Commercial Applications
[0160] As discussed above, and further demonstrated in the following examples, the glycosyltransferases of the present invention are improved in several respects over the wild-type enzyme, including melting temperature, half-life, solvent tolerance, and chemical stability. Such improvements are highly relevant commercially. The enzymes are particularly suitable for use as greener alternatives to current fabric and textile dyeing processes, but may also be used in many other areas.
[0161] Example
[0162] In the following, several different mutant UGT polypeptides were studied and characterized. Tables 2, 3 and 4 provide an overview of these mutant enzymes and their amino acid mutations relative to the PtUGT1 wild type. The mutant enzymes in this application are generally referred to by the "mutant number".
[0163] General approach
[0164] Mutant design
[0165] Variants of wild-type PtUGT1 (SEQ ID NO. 2) were constructed using the original expression vector pTMH307 (SEQ ID NO. 12) as a template (Hsu et al. 2018; GenBank accession number MF688772). Mutations were introduced by PCR using USER cloning (NEB). The primers used for mutagenesis are shown in Table 1. All constructs were verified by DNA sequencing services (Eurofins) before transformation into chemically competent Escherichia coli BL21 Star (DE3) (ThermoFisher Scientific) as recommended by the manufacturer.
[0166]
[0167]
[0168]
[0169]
[0170]
[0171]
[0172]
[0173] Construction of plasmid containing Mut87
[0174] The plasmid of mutant 87 was prepared during the further development of the plasmid of an earlier mutant:
[0175] The plasmid of Mutant 87 was prepared using the primers "GV296 / 297LG" (Table 1) on the plasmid of Mutant 86.
[0176] The plasmid of Mutant 86 was prepared using the primer "G222D" (Table 1) on the plasmid of Mutant 85.
[0177] The plasmid of Mutant 85 was prepared using the primer "E75P" (Table 1) on the plasmid of Mutant 81.
[0178] The plasmid of Mutant 81 was prepared using the primer "G430K" (Table 1) on the plasmid of Mutant 80.
[0179] The plasmid of Mutant 80 was prepared using the primer "T388A" (Table 1) on the plasmid of Mutant 77.
[0180] The plasmid of Mutant 77 was prepared using the primer "S413K" (Table 1) on the plasmid of Mutant 74.
[0181] The plasmid of Mutant 74 was prepared using the primer "I188L" (Table 1) on the plasmid of Mutant 71.
[0182] The plasmid of mutant 71 was prepared using the primer "S110V" (Table 1) on the plasmid of mutant 48.
[0183] The plasmid of mutant 48 was prepared using primer "Q86K" (Table 1) on the original expression vector pTMH307.
[0184] Construction of plasmid containing Mut88
[0185] The plasmid of Mutant 88 was prepared using primer "F381V-Mut88" (Table 1) on the plasmid of Mutant 87. Details on how to prepare the plasmid of Mutant 87 are described above.
[0186] Construction of plasmid containing Mut90
[0187] The plasmid of Mutant 90 was generated using primers "A388C / A399C-Mut90" (Table 1) on the plasmid of Mutant 88. Details on how to prepare the plasmid of Mutant 88 are provided above.
[0188] Expression and purification of PtUGT1 WT and variants
[0189] In order to express PtUGT1 variant, 10ml pre-cultured cells carrying the corresponding expression vector were grown overnight in 2xYT medium containing ampicillin (100 μg / ml) and then used to inoculate 1L culture of 2xYT medium under the condition of ampicillin selection. The culture was grown at 37°C in a MaxQ8000 incubator (Thermo Fisher Scientific, Germany) at 200rpm and induced when OD600 was about 1 with 0.2mM isopropyl-β-D-thiogalactoside (IPTG). The culture was then cultivated for 21h at 18°C to realize protein expression, and cells were harvested by centrifugation. The cell pellet was suspended in 50mM HEPES pH 7.0, 300mM NaCl and 40mM imidazole pH 8.0. The cell suspension was lysed by Avestin Emulsiflex C5 (ATAScientific Pty Ltd., Australia) homogenizer for 2 cycles and treated with DNase I (Merck). Cell debris was removed by centrifugation at 15000 g for 20 min at 4°C. The clarified extract was loaded onto a Ni Sepharose Fast Flow column (HisTrap affinity column, GE Healthcare, US) and purified using System (GE Healthcare, US) protein purification.After washing the column with 20 times of volume buffer (50mM HEPES pH 7.0, 300mM NaCl and 40mM imidazole pH 8.0), the gradient of 40-500mM imidazole on the same buffer is used for elution.Use NuPAGETM 4-12% Bis-Tris protein gel (Thermo Fisher Scientific, US) to analyze the peak fraction by SDS-PAGE, the protein gel is stained with Instant Blue (Expedeon Ltd. UK), and is collected, and 50,000MWCO Amicon Ultra-15 centrifugal filter (Merck Millipore, Germany) is used to concentrate and be stored in 25mM HEPES pH 7, 50mM NaCl and 1mM DTT.
[0190] The final protein concentration was determined by absorbance results at 280 nm using a ND-1000 spectrophotometer (Fischer scientific) and the corresponding theoretical extinction coefficient.
[0191] Tm experiment-Differential scanning fluorimetry (DSF)
[0192] The melting temperature (Tm) of PtUGT1 and variants was measured by DSF using a protein thermal shift staining kit (ThermoFisher Scientific) and a qPCR QuantStudio5 machine. The dye solution (1000x) was diluted to a final (2x) in buffer 2x (100mM HEPES pH7, 100mM NaCl). 10pL of dye solution 2x was mixed with 10μL of a protein sample at 0.8mg / mL in H2O and transferred to a qPCR multiwell plate. The multiwell plate was centrifuged at 1000rpm for 30 seconds and transferred to the qPCR machine. The protocol started with an incubation of 2 minutes at 25°C, after which the temperature was increased to 99°C at 0.05°C / second, and finally incubated at 99°C for 2 minutes. The thermal shift assay is a technique for quantifying changes in protein denaturation temperature, and is therefore used herein to identify mutations that are beneficial to protein thermal stability. Measurements were performed in triplicate / quadruplicate. Raw data were analyzed using Protein Thermal Shift. TM Software v1.x analysis.
[0193] Example 1: Disulfide bridge mutants
[0194] 1.1 Mutant design
[0195] First we focus on the introduction of disulfide bridges. To do this, we used the program SSBOND (Hazes and Dijkstra, 1988), which analyzes protein structure and identifies residue pairs that may form disulfide bridges when they are mutated to cysteine based on the distance of Cβ atoms, Cβ / Sγ angle and Sγ1 / Sγ2 angle and the web-based tool Disulfide by Design 2.0 (Douglas B Craig and Alan A Dombkowski). The program identified 35 residue pairs that may form intramolecular disulfide bridges and 2 residue pairs that may form intermolecular disulfide bridges. The details of these mutants are shown in Table 2.
[0196]
[0197]
[0198] 1.2 Melting Temperature
[0199] The melting temperatures (Tm) of PtUGT1 wild type and disulfide bridge mutants were measured as described above. The results are shown in Figure 3 It can be seen that although most mutants perform roughly the same as (or worse than) the wild type, there are a few mutants whose Tm is increased compared to the wild type, such as mut13, mut23 and mut28.
[0200] These best performing mutations were combined into different double or triple mutations. These mutants had Tm higher than any single mutant (see Figure 4 ), but unfortunately, their activity was poor (data not shown).
[0201] Example 2: Common mutants
[0202] 2.1 Mutant design
[0203] Secondly, a consensus scheme was used. First, the sequences of PtUGT1 homologues with 60% or higher sequence identity were collected and multiple sequence homology comparisons were performed using NCBI sequence blast searches. Subsequently, a multiple sequence comparison of all sequences was created using MultiblastClustalW2 (reference?), each alignment column was manually / visually scanned, and the positions of underrepresented original PtUGT1 amino acids were identified. Using the structures of PtUGT1 (5NLM) and two homologues (2ACV and 2VG8) for the consensus method, potential mutations were rationally analyzed, and the final number of variants was set to 34. Mutants of PtUGT1 were constructed to make their specific positions more similar to most known homologues. The details of these mutants are shown in Table 3.
[0204]
[0205]
[0206] *Mut45=Mut(41+42+43+44)
[0207] **Mut46=Mut(39+40+41+42+43+44)
[0208] 2.2 Melting Temperature
[0209] The melting temperatures (Tm) of PtUGT1 wild type and consensus mutants were measured as described above. The results are shown in Figure 5 For the consensus mutagenized enzymes, more mutants with increased Tm compared to the wild type were found, such as mut39, mut41, mut44, mut45, mut46, mut48, mut48B, mut55, mut58, mut60, mut63, mut64, and mut68.
[0210] Example 3: Combination of mutations
[0211] 3.1 Mutant design
[0212] Different combinations of mutations were tested, as shown in Table 4.
[0213]
[0214]
[0215] 3.2 Melting Temperature
[0216] The melting temperatures (Tm) of PtUGT1 wild type and combined mutants were measured as described above. The results are shown in Figure 6 , and are further summarized in Table 4. For the combined mutant enzymes, it was found that the Tm of the mutants was further increased compared to the wild type, and for mut90, an increase of up to 15°C in the melting temperature was obtained compared to the wild type.
[0217] The best performing mutants were selected for further study: mut87, mut88, mut90. The selection was based primarily on the increase in melting temperature and the relative activity measured compared to wild type.
[0218]
[0219]
[0220] All designated mutations are referenced to wild-type PtUGT (SEQ ID NO 2). Black shading in the table indicates the presence of a mutation in the mutant.
[0221] ΔTm is the change in Tm compared to the wild-type enzyme (in 50 mM HEPES, 50 mM NaCl, pH 7). Relative activity is the activity of the mutant compared to the wild-type activity at 40°C (in citrate-phosphate buffer, pH 7).
[0222] 3.3 Relative activity at different temperatures
[0223] Relative activity experiments were also performed at 40, 55 and 60°C.
[0224] The relative activities of PtUGT1 variants (mut87, mut88, and mut90) compared to WT activity were calculated in triplicate reactions using an Ultimate 3000 Series instrument (Thermo Scientific) and a Kinetex 2.6 μm C18 100×4.6 mm analytical column (Phenomenex), product peaks were monitored via reverse phase HPLC. MilliQ water and acetonitrile containing 0.1% formic acid were used as mobile phases A and B, respectively. PCR strips containing 200 μl of reaction mixture (1 mM UDP-glucose, 50 mM citrate-phosphate buffer at pH 7, 500 μM DCP and 1 ug enzyme) were incubated at 40°C for 10 minutes. The reaction was stopped using a multi-step program and analyzed at 290 nm (starting from 5% B, rising to 25% B at 1.5 min, rising to 30% B at 3.5 min, rising to 100% B at 6.25 min, and remaining at 100% B until 7 min, and the gradient was reduced to 0% B at 8 min, and remained at 0% B until 9 min). Chromeleon software (Thermo Scientific) was used for peak integration and data processing.
[0225] The activities of the three mutants at 40°C were comparable to or slightly lower than those of the wild-type enzyme ( Figure 7 A). However, at 55°C and 60°C, the mutant significantly outperformed the wild-type enzyme, which was inactive at these temperatures ( Figure 7 B and 7C). At 55°C, the mutant performed better, or at least comparable to the activity of the wild type measured at 40°C. At 60°C, the mutant still maintained half the activity of the wild type recorded at 40°C.
[0226] 3.4 Half-life
[0227] The half-life / shelf life time is defined as the amount of time an enzyme can be pre-incubated at a defined temperature so that it has 50% residual activity compared to the activity without pre-incubation.
[0228] To determine the half-life / shelf life of PtUGT1 WT and variants, stock solutions of free enzyme in buffer (100 mM HEPES pH 7, 100 mM NaCl) were incubated at 45 °C or room temperature for different time periods and their residual activity was then analyzed using the same procedure described in the “Relative activity experiment” and compared with the activity without a pre-incubation step.
[0229] At 45°C, the residual activity of the wild-type enzyme decreased by >90% after 5h 20min. Meanwhile, the residual activity of the mutant enzyme remained fairly constant over the same incubation period. It appeared to have dropped to about 60% after 24h, and after 96h the residual activity dropped to between about 35-45%. Figure 8 and Fig. 9 .
[0230] 3.5 Solvent resistance
[0231] To determine the solvent tolerance of PtUGT1 WT and variants, relative activities were analyzed using the same procedure as described in “Relative activity experiments” with the addition of 15% v / v acetone, acetonitrile, or isopropanol and compared with the activities without the addition of any organic solvents. Fig.10 As can be seen, the mutant has some activity in all three solvents, while the wild type shows no activity in acetonitrile and isopropanol.
[0232] 3.6 Chemical stability
[0233] Chemical stability is defined as the property of a polypeptide to maintain structural integrity and activity in the presence of chemicals such as indoxyl, indoxyl derivatives or DCP. Chemical stability was tested here against DCP, which is generally considered to be "harsh" for enzymes and may reduce or destroy the activity of the enzyme.
[0234] Reactions were performed in the presence of 15 mg / L enzyme (PtUGT1 WT or mutant 87), 4 mM 3,4-dichlorophenol (DCP), 6 mM UDP-Glc, and 0.5 M citrate pH 6.2. 50 μL of the reaction was loaded into HPLC vials with inserts and incubated at 20°C for 48 h before analysis via reverse phase HPLC using an Ultimate 3000 series instrument (ThermoScientific) and a kinetex 2.6 μm C18 100×4.6mm analytical column (Phenomenex). MilliQ water and acetonitrile containing 0.1% formic acid were used as mobile phases A and B, respectively. Chromeleon software (Thermo Scientific) was used for monitoring and data processing. The flow rate of the method for separating analytes was 1mL / min, and started with 2% B for 30 seconds, followed by 35% B for 1 minute, followed by a gradient of 35% to 80% B for 1.5min. Afterwards, B was increased to 98% for 1.2min, and finally reduced to 2% B for the last 0.8min. DCP and its glucoside were detected at 280nm.
[0235] exist Fig.11 In the HPLC chromatogram, only the substrate was present in the reaction with the WT enzyme, but no product at all. Therefore, the WT enzyme could not withstand the higher concentration of DCP and was therefore inactive. A similar lack of chemical stability was reported by Petermeier et al. 2021. In the reaction with Mut87, there was a distinct peak for the product DCP-glucoside, which means that Mut87 has chemical stability for this compound, while the WT does not.
[0236] Example 4: Dyeing of denim
[0237] 4.1 Synthesis of indigoside from indoxyl acetate
[0238] Proof of concept for the synthesis of indigoside from high concentrations of indoxyl acetate (100 mM) was performed in triplicate in an anaerobic chamber using glass HPLC vials stirred with a small magnet at 30°C. The reactions included 3.5 mg indoxyl acetate, 90 mM phosphate-citrate buffer (pH 8), 1 mM UDP, 200 mM sucrose, 2 U esterase from Bacillus subtilis (Sigma Aldrich), and different concentrations of PtUGT1 / SuSy, always at a molar ratio of 1:5 (50 μg, 20 μg, 10 μg, 5 μg for PtUGT1 WT or Mut 87; and 432.5 μg, 173 μg, 86.7 μg, 43.3 μg for SuSy). Sucrose synthase (SuSy) converts sucrose and uridine 5'-diphosphate (UDP) into UDP-glucose. The reaction was started by adding all three enzymes (esterase, PtUGT1 and SuSy) and the progress was followed by HPLC using the same method as in the "Relative Activity Experiment". Samples were collected at 1, 2, 3, 6, 12, 24 and 32 hours.
[0239] Fig.12It was shown that under the conditions tested here, the WT enzyme did not produce any indigoside from indoxyl acetate, whereas the Mut87 enzyme produced indigoside from indoxyl acetate. Presumably, the high concentration of substrate inactivated the WT enzyme; this did not appear to be a problem for the mutant enzyme.
[0240] 4.2 Denim dyeing
[0241] A 20 cm2 denim disk to be dyed (radius 1.784 cm, diameter 3.57 cm, weight 802 + / - 2 mg) was dyed in 3 mL of water at pH 9 with 30 μmol indigo (prepared above) and 1 mg rye β-glucosidase 1 (SEQ ID NO. 9). The disk was turned over every 5 min for 15 min at room temperature, then left at room temperature for 1 h, then washed with water and soap, and dried overnight at room temperature.
[0242] like Fig.13 As can be seen, the indigoside produced is capable of dyeing denim. The coloration is further assigned to the CIEL in Table 6.
[0243]
[0244]
[0245] Example 5: Glycosylation of other indoxyl derivatives
[0246] The above examples demonstrate that the UGT mutants of the present invention are capable of glycosylation of indoxyl. We further demonstrate herein that the UGT mutants are also capable of glycosylation of other indoxyl derivatives. Fig.14 , a diagram of a selection of such indoxyl derivatives of interest.
[0247] 5.1 6-Bromo-indoxyphenol
[0248] Reactions were performed in PCR tube strips at 30°C. Reaction components are specified in Table 7. Start with esterase from Bacillus subtilis in added buffer using a multichannel pipette.
[0249]
[0250] *UGT stock solution: WT = 9.04 mg / ml; Mut 87 = 1.57 mg / ml; Mut 88 = 12.32 mg / ml; Mut 90 = 4.4 mg / ml. Storage buffer: 25 mM HEPES pH 7, 50 mM NaCl.
[0251] **3.5 mM 6-bromo-indoxyl-acetate in water was dissolved in a bath sonicator at room temperature.
[0252] When 6-bromo-indoxyl acetate is treated with esterase, acetate and 6-bromo-indoxyl are formed. If further exposed to air, dimers spontaneously form from 6-bromo-indoxyl, which have a different purple color (called Tyrian purple or royal purple). Fig.15 As demonstrated, it is clear that the two negative controls without the addition of UGT enzymes or UDP-glucose developed this purple color. Meanwhile, for the samples with the addition of UGT enzymes, 6-bromo-indoxyl was glycosylated (after removing the acetate) and thus "blocked" from forming dimers, so no color was formed.
[0253] This showed that PtUGT1 (wild type) and all mutants tested were active towards 6-bromo-indoxyl.
[0254] 5.2 5-Bromo-4-chloro-3-indoxyl
[0255] Reactions were performed in PCR tube strips at 30°C. Reaction components are specified in Table 8. Start with esterase from Bacillus subtilis in added buffer using a multichannel pipette.
[0256]
[0257] *UGT stock solution: WT = 9.04 mg / ml; Mut 87 = 1.57 mg / ml; Mut 88 = 12.32 mg / ml; Mut 90 = 4.4 mg / ml. Storage buffer: 25 mM HEPES pH 7, 50 mM NaCl.
[0258] **3.5 mM *5-Bromo-4-chloro-indoxyl-acetate in water was dissolved in a bath sonicator at room temperature.
[0259] When 5-bromo-4-chloro-indoxyl acetate is treated with esterase, acetate and 5-bromo-4-chloro-indoxyl are formed. If further exposed to air, dimers spontaneously form from 5-bromo-4-chloro-indoxyl, which have a bright blue color. Fig.16 As demonstrated, it is clear that the negative control without the addition of UGT enzyme develops this blue color. Meanwhile, for the sample with the addition of UGT enzyme, 5-bromo-4-chloro-indoxyl is glycosylated (after removal of acetate) and thus "blocked" from forming dimers, so no color is formed.
[0260] It was thus demonstrated that PtUGT1 (wild type) and all mutants tested were active towards 5-bromo-4-chloro-indoxyl.
[0261] 5.3 Other indoxyl derivatives
[0262] 6-Chloroindoxyl, 5-bromoindoxyl, 5-bromo-6-chloroindoxyl, thioindoxyl and 5,7-dibromoindoxyl are also glycosylated by the enzymes of the invention. This can be demonstrated in a similar manner to that shown in Sections 5.1 and 5.2 above, where the acetate form of the molecule is used as the starting material and an esterase is used in combination with a UTG enzyme. The action of the UGT enzyme prevents the spontaneous dimerization of the indoxyl derivatives, resulting in glycosylation of the compound.
[0263] Example 6: Melting Temperature and Chemical Stability of UGT Enzymes in the Prior Art
[0264] The following prior art UGT enzymes were tested:
[0265] · PtUGT2 (SEQ ID NO. 200): Polygonum indigofera UGT isoform 2 (as disclosed in sequence #4 in WO2016 / 141207). PtUGT2 has five mutations compared to SEQ ID NO. 2: delS1, V19M, G225A, E230Q and A423D.
[0266] · PtIGS (SEQ ID NO. 202): Polygonum indigofera glycosyltransferase; Uniprot ref. A0A2L2R220. PtIGS has three mutations compared to SEQ ID NO. 2: delS1, V19M and A423D.
[0267] The enzymes were expressed and purified as disclosed herein.
[0268] The melting temperatures (Tm) of prior art UGT enzymes were measured as described herein ('General Methodology' section). The results are summarized in Table 9 and are given in Table 9. Fig.17 , where Δ(Tm) is relative to PtUGT1 WT (SEQ ID NO. 2).
[0269]
[0270] The study found that the melting temperature of PtUGT2 was not significantly different from that of WT PtUGT1, while the melting temperature of PtIGS was lower than that of PtUGT1 WT.
[0271] Chemical stability was measured as described herein (Example 3.6). The results are presented in Fig.18 The HPLC chromatogram showed that in the reaction using Mut87, the product DCP-glucoside had a clear peak, which means that Mut87 is chemically stable to this compound; whereas in the reactions using the wild-type enzyme and other prior art enzymes, only a very small DCP-glucoside peak was found, so the prior art enzymes could not withstand high concentrations of DCP and were therefore inactive.
[0272] References
[0273] Lee et al. 2004. One-pot enzymatic synthesis of UDP-D-glucose from UMP and Glucose-1-Phosphase using ATP regeneration system. Journal of Biochemistry and Molecular Biology, Vol. 37, No. 4, July 2004, pp. 503-506
[0274] Frederik De Bruyn et al., Development of an in vivo glucosylation platform by coupling production to growth: Production of phenolic glucosides by a glycosyltransferase of Vitis vinifera. Biotechnol. Bioeng(2015)112, 1594-1603, https: / / doi.org / 10.1002 / bit.25570
[0275] Craig, D.B., Dombkowski, A.A. Disulfide by Design 2.0: a web-based tool for disulfide engineering in proteins. BMC Bioinformatics 14, 346(2013). doi.org / 10.1186 / 1471-2105-14-346
[0276] B W Dijkstra. Model building of disulfide bonds in proteins with known three-dimensional structure B Hazes 1, PMID: 3244694 DOI: 10.1093 / protein / 2.2.119
[0277] Hsu, T.M. et al., Employing a biochemical protecting group for a sustainable indigo dyeing strategy. Nat. Chem. Biol. 14, 256 - 261 (2018).
[0278] Inoue et al. 2017. Characterization of UDP - glucosyltransferase from Indigofera tinctoria. Plant Physiol Biochem. 2017 Dec; 121:226 - 233. Doi: 10.1016 / j.plaphy.2017.11.002. Epub 2017 Nov 6.
[0279] Philipp Petermeier, Cristina Fortuna, Kathrine M. Hübschmann, Gonzalo N. Bidart, Thomas David Teze, Ditte H. Welner, and Selin Kara. ACS Sustainable Chemistry & Engineering 2021 9(25), 8497 - 8506. DOI: 10.1021 / acssuschemeng.1c01536。
Claims
1. A polypeptide having glycosyltransferase activity (enzyme classification EC: 2.4.1.-), wherein the amino acid sequence of the polypeptide has at least 75% sequence identity with SEQ ID NO.2, and wherein the amino acid sequence comprises (i) one or more amino acid residue substitutions selected from the group consisting of E75P, Q86K, S110V, I188L, G222D, G296L, V297G, F381V, T388A, S413K and G430K relative to SEQ ID NO.2, and / or (ii) amino acid residue substitutions T388C and A399C relative to SEQ ID NO.
2.
2. The polypeptide according to claim 1, wherein the half-life of the glycosyltransferase activity of the polypeptide at 45°C is increased compared to SEQ ID NO.
2.
3. The polypeptide according to claim 1 or 2, wherein the amino acid sequence comprises the amino acid residue substitutions E75P, Q86K, S110V, I188L, G222D, G296L, V297G, S413K and G430K relative to SEQ ID NO.
2.
4. The polypeptide according to claim 3, wherein the amino acid sequence further comprises (i) one or more amino acid residue substitutions selected from F381V and T388A relative to SEQ ID NO. 2, and / or (ii) amino acid residue substitutions T388C and A399C relative to SEQ ID NO.
2.
5. The polypeptide according to claim 3, wherein the amino acid sequence further comprises: (i) the amino acid residue substitution T388A relative to SEQ ID NO. 2, or (ii) amino acid residue substitutions F381V and T388A relative to SEQ ID NO. 2, or (iii) amino acid residue substitutions F381V, T388C and A399C relative to SEQ ID NO.
2.
6. A composition comprising: (i) a polypeptide having glycosyltransferase activity according to any one of claims 1 to 5, (ii) a compound comprising a reactive group, and (iii) a nucleotide sugar.
7. The composition of claim 6, wherein the compound is an indoxyl compound; and preferably, wherein the composition contains less than 2% free oxygen.
8. The composition of claim 6 or 7, wherein the nucleotide sugar is UPD-glucose.
9. A kit of parts comprising: (i) a polypeptide having glycosyltransferase activity according to any one of claims 1 to 5, and (ii) a polypeptide having β-glucosidase activity (enzyme class EC 3.2.1.21).
10. A method for glycosylation of a compound, comprising the steps of: a. providing (i) a compound comprising a reactive group, (ii) a polypeptide having glycosyltransferase activity according to any one of claims 1 to 5, and (iii) a nucleotide sugar, b. mixing the components provided in step (a), c. reacting the mixture to obtain a glycosylated compound.
11. The method according to claim 10, wherein the compound provided in step (a) is an indoxyl compound, wherein the glycosylated compound obtained in step (c) is a soluble glycosylated indoxyl dye precursor, and wherein steps (b) and (c) are preferably carried out under reaction conditions wherein there is less than 2% free oxygen.
12. The method according to claim 11, wherein the indoxyl compound is selected from the group consisting of indoxyl, 6-bromo-indoxyl, 5-bromo-4-chloro-indoxyl, 6-chloro-indoxyl, 5-bromo-indoxyl, 5-bromo-6-chloro-indoxyl, thioindoxyl and 5-bromo-7-bromo-indoxyl.
13. The method according to any one of claims 10-12, wherein the nucleotide sugar is UDP-glucose.
14. A method for dyeing a product, comprising the steps of: a. providing (i) an indoxyl compound, (ii) a polypeptide having glycosyltransferase activity according to any one of claims 1 to 5, (iii) a nucleotide sugar and (iv) a polypeptide having β-glucosidase activity (enzyme classification EC 3.2.1.21), b. mixing components (i), (ii) and (iii) provided in step (a), preferably under reaction conditions in which there is less than 2% free oxygen, c. reacting the mixture to obtain a soluble glycosylated indoxyl dye precursor, d. mixing the dye precursor with the product and the β-glucosidase under reaction conditions in which free oxygen is present to obtain a dyed textile, The product is selected from the group consisting of yarn, textiles and fabrics.
15. Use of the polypeptide having glycosyltransferase activity according to any one of claims 1 to 5 for glycosylation of a compound, wherein the compound comprises a reactive group.
16. The use according to claim 15, wherein the compound is an indoxyl compound, and wherein the glycosylated compound is for use in a textile dyeing process.
Citation Information
Cited By
Sucrose phosphorylase mutant and application thereof in preparation of AA-2G
CN122588043A
Sucrose phosphorylase mutants and their use in the preparation of aa-2g
CN122588043B
